Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark

More Jobs >>

Events

Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA

More Events >>

Related Tags >> Vaccine cancer vaccine Hawaii Biotech phase I

Clinical Trial Results News

Most Popular Clinical Trial Results Story

Novavax VLP vax works against 1918 Spanish flu

April 16, 2009 — 9:04am ET | By John Carroll

Novavax says that a virus-like particle vaccine it developed was successful in guarding against both the deadly 1918 Spanish flu strain as well as an H5N1 strain in a preclinical study. Researchers Read more...

Clinical Trial Results Press Releases

Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma
Medicago reports positive Phase II final results for its avian flu pandemic vaccine
MEDIAN Technologies Unveils a Unique Product for Oncology Clinical Trials: CTIS
Marine Polymer Technologies Announces Positive Results of Talymed™ Clinical Trial Published in the Journal of the American

Latest Headlines

Study: Immunotherapy helped prostate cancer patients live longer
January 27, 2010
HPV vax successfully treats precancerous lesions
November 5, 2009
Vical touts strong immune response in swine flu vax study
September 10, 2009
Personalized cancer vax improves survival rates
July 30, 2009
Typhoid vax can protect entire neighborhoods
July 23, 2009
Novavax VLP vax works against 1918 Spanish flu
April 16, 2009
Hawaii Biotech: Phase I West Nile vax trial a success
February 25, 2009
In Phase III, Gardasil prevents HPV in men
November 13, 2008
Allergy Therapeutics advances ragweed vax
September 25, 2008
Transgene shares up on positive cancer vax data
September 18, 2008
Experimental vax targets aggressive tumors
September 18, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK